/

Ascidian Therapeutics

Developing exon-editing RNA therapeutics for genetic diseases.

BiotechnologyPharmaceuticals

ascidian-tx.com ↗

Company facts

Founded: 2020
Employees: 62
Headquarters: United States
Type: Private
Funding: Series A · $40M · 2023